(Q40799911)

23 September 2017

title

Oral immunisation of mice with live Japanese encephalitis virus induces a protective immune response (English)

1 reference

Japanese encephalitis virus

23 September 2017

main subject

0 references

Japanese encephalitis

1 reference

Ramakrishna C

1

1 reference

23 September 2017

Desai A

2

1 reference

23 September 2017

Shankar SK

3

1 reference

23 September 2017

Chandramuki A

4

1 reference

23 September 2017

Ravi V

5

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

23 September 2017

number of pages

7

1 reference

inferred from page(s)

published in

Vaccine

1 reference

23 September 2017

volume

17

1 reference

23 September 2017

issue

23-24

1 reference

23 September 2017

page(s)

3102-3108

1 reference

Side-effects with Japanese encephalitis vaccine

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900137-1

7 January 2021

Adverse reactions to Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900137-1

7 January 2021

Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900137-1

7 January 2021

Acute disseminated myelitis after Japanese B encephalitis vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900137-1

7 January 2021

Allergic mucocutaneous reactions to Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900137-1

7 January 2021

Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900137-1

7 January 2021

Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900137-1

7 January 2021

New strategies for using mucosal vaccination to achieve more effective immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900137-1

7 January 2021

Expression of rabies virus glycoprotein from a recombinant vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900137-1

7 January 2021

Expression of hepatitis B surface antigen in transgenic plants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900137-1

7 January 2021

The mucosal immune system: from fundamental concepts to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900137-1

7 January 2021

10.1016/S0264-410X(99)00137-1

Identifiers

DOI

1 reference

23 September 2017

1 reference